COEPW

Market Cap

$57.05K

P/E Ratio

—

EPS

—

Dividend Yield

0.00%

52-Week Range

$0.01 — $0.01

Volume

12.32K

Avg Volume

47.47K

Beta

—

P/E (TTM)

—

Forward P/E

—

PEG Ratio

0.23

P/S (TTM)

84.45

P/B (TTM)

4.58

P/FCF

—

EV/EBITDA

—

EV/Sales

—

ROE (TTM)

-1.38%

ROA (TTM)

-0.60%

ROIC

—

Gross Margin

0.21%

Operating Margin

-26.38%

Net Margin

—

Debt/Equity

0.02

Current Ratio

2.21

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-1.44%

EPS Growth (5Y)

-456.31%

Sales Growth (3Y)

-0.33%

Sales Growth (5Y)

+0.09%

EPS Est (This Year)

$-3.40

EPS Est (Next Year)

$-3.60

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$1.12

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

5.76M

Float

5.11M

Free Float %

88.69%

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

NASDAQ

IPO Date

2020-12-17

Employees

4

CEO

David Mehalick

Index Membership

—

Website

https://coeptispharma.com